International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers.
Metcalfe KA, Birenbaum-Carmeli D, Lubinski J, Gronwald J, Lynch H, Moller P, Ghadirian P, Foulkes WD, Klijn J, Friedman E, Kim-Sing C, Ainsworth P, Rosen B, Domchek S, Wagner T, Tung N, Manoukian S, Couch F, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA, et al. Among authors: lynch h.
Int J Cancer. 2008 May 1;122(9):2017-22. doi: 10.1002/ijc.23340.
Int J Cancer. 2008.
PMID: 18196574
Free PMC article.